MINT Venture Partners is a Seoul-based venture capital firm and global venture studio investing in biotech and healthcare startups. The firm focuses on drug discovery, diagnostics and devices, digital healthcare, medical care and wellness, including small molecules, antibody, cell and gene therapy, medical devices, telemedicine, AI-based healthcare and digital therapeutics. It has seed-stage investment activity and portfolio exposure across South Korea, the United States, the United Kingdom, Canada and Singapore.